Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Cardiology|April 3, 2012
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three yearsAlexandra J Lansky, Somjot S Brar, Manejeh Yaqub, et al.
The American Journal of Cardiology|August 10, 2010
Comparison of everolimus- versus paclitaxel-eluting stents implanted in patients with diabetes mellitus as evaluated by three-dimensional intravascular ultrasound analysisHiromasa Otake, Junya Ako, Masao Yamasaki, et al.
The American Journal of Cardiology|January 25, 2011
Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial)Vivian G Ng, Alexandra J Lansky, James B Hermiller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 23, 2012
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trialMasao Yamasaki, Ichizo Tsujino, Moyses O Lima-Filho, et al.
Journal of the American College of Cardiology|April 26, 2011
Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trialGregg W Stone, Ali Rizvi, Krishnankutty Sudhir, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trialAlexandra J Lansky, Manejeh Yaqub, James B Hermiller, et al.
Minerva Cardiology and Angiology|May 28, 2024
Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR RegistryDavid M Leistner, Rajiv Rampat, Michael Haude, et al.
The American Journal of Cardiology|May 12, 2007
Serial intravascular ultrasonic study of outcomes of coronary culprit lesions with plaque rupture following bare metal stent implantation in patients with angina pectorisSeung-Ho Hur, Ali H M Hassan, Rachna Rekhi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 26, 2012
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomesMarie-Claude Morice, Ghada W Mikhail, Fina Mauri i Ferré, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2012
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trialsJames B Hermiller, Krishnankutty Sudhir, Robert J Applegate, et al.
Pageof 10